Skip to content
Course Correcting for Long-Term Success episode artwork

Feb 9, 2022 25 min

Course Correcting for Long-Term Success

from Running Through Walls Hosted by Venrock, a venture capital firm

Venrock partner Andrew Gottesdiener speaks with Jigar Raythatha, former CEO of Constellation Pharmaceuticals, about lessons learned from his time at Constellation. As Constellation has evolved from an early-stage company to being acquired by MorphoSys, Raythatha dives into its many life-cycles, his heavy involvement in the recruitment process, and the decision to conduct a PIPE financing. Raythatha also shares the characteristics to look for in an investor syndicate and the challenges of scaling a public company.

Episode details come from the podcast's RSS feed.

Embed this episode

Ready to play

Course Correcting for Long-Term Success

0:00 25:51

No transcript yet.

Requests help us decide what to transcribe next.

Frequently asked questions

How long is this episode of Running Through Walls?

This episode is 25 minutes long.

When was this Running Through Walls episode published?

This episode was published on February 9, 2022.

Can I download this Running Through Walls episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.